| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |